Header Logo

Connection

MICHAEL BRAUN to Tamoxifen

Back to Details
This is a "connection" page, showing publications MICHAEL BRAUN has written about Tamoxifen.
MICHAEL BRAUN
Connection Strength
0.080
Tamoxifen
  1. Endocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance in HR+/HER2- Early Breast Cancer. J Clin Oncol. 2022 08 10; 40(23):2557-2567.
    View in: PubMed
    Score: 0.041
  2. TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer. Cancer Med. 2021 12; 10(23):8581-8594.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.